Relaxo Footwears (RELAXO)₹290.70−1.79%Footwear
In the Mar 2026 quarter (standalone), Relaxo Footwears reported sales of ₹752 Cr, up 8.0% from Mar 2025, and net profit of ₹68.13 Cr, up 21.4% year on year. For the year to Mar 2026, sales were ₹2,705 Cr and net profit ₹179 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 740 | 716 | 715 | 749 | 749 | 680 | 668 | 696 | 655 | 630 | 669 | 752 |
| Expenses | 633 | 626 | 628 | 629 | 651 | 594 | 585 | 585 | 556 | 549 | 601 | 629 |
| Operating Profit | 108 | 91.94 | 86.91 | 120 | 99.04 | 88.03 | 82.98 | 112 | 98.99 | 80.94 | 69.01 | 124 |
| OPM % | 15.0% | 12.9% | 11.9% | 16.0% | 12.9% | 12.9% | 11.9% | 15.9% | 14.9% | 13.0% | 9.9% | 17.0% |
| Other Income | 6.98 | 10.98 | 5.98 | 4.98 | 4.98 | 6.98 | 6.98 | 7.98 | 10.97 | 11.97 | 10.97 | 11.97 |
| Interest | 3.99 | 5.01 | 4.99 | 4.99 | 5.01 | 5.01 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 6.01 |
| Depreciation | 34.96 | 36.95 | 37.93 | 37.98 | 38.97 | 39.92 | 39.92 | 38.93 | 39.96 | 38.95 | 38.96 | 38.92 |
| Profit before tax | 76.21 | 60.11 | 51.10 | 82.16 | 60.17 | 50.14 | 45.08 | 75.24 | 66.22 | 49.14 | 36.09 | 91.21 |
| Tax % | 26.0% | 27.0% | 24.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% | 26.0% | 26.0% | 26.0% | 25.0% |
| Net Profit | 56.18 | 44.12 | 39.13 | 61.19 | 44.10 | 37.07 | 33.10 | 56.14 | 49.15 | 36.08 | 27.08 | 68.13 |
| EPS (Rs) | 2.27 | 1.79 | 1.56 | 2.48 | 1.79 | 1.49 | 1.34 | 2.27 | 1.97 | 1.46 | 1.08 | 2.73 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,670 | 1,634 | 1,945 | 2,297 | 2,413 | 2,363 | 2,659 | 2,788 | 2,921 | 2,794 | 2,705 | 2,706 |
| Expenses | 1,431 | 1,404 | 1,645 | 1,971 | 2,005 | 1,865 | 2,243 | 2,448 | 2,511 | 2,412 | 2,334 | 2,334 |
| Operating Profit | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 374 | 373 |
| OPM % | 13.9% | 13.9% | 15.9% | 13.9% | 16.9% | 20.9% | 15.9% | 11.9% | 14.0% | 13.9% | 14.0% | 13.8% |
| Other Income | 6.98 | 13.95 | 3.99 | 11.97 | 7.97 | 21.92 | 22.93 | 15.95 | 28.90 | 26.93 | 45.87 | 45.88 |
| Interest | 22.99 | 14.99 | 8.99 | 8.99 | 18.98 | 18.99 | 17.01 | 21.99 | 20.99 | 23.98 | 22.01 | 20.98 |
| Depreciation | 46.90 | 50.96 | 53.94 | 61.90 | 109 | 110 | 114 | 125 | 147 | 158 | 157 | 157 |
| Profit before tax | 178 | 178 | 245 | 269 | 293 | 392 | 312 | 210 | 270 | 231 | 242 | 243 |
| Tax % | 32.0% | 33.0% | 34.0% | 35.0% | 22.0% | 25.0% | 25.0% | 26.0% | 26.0% | 26.0% | 26.0% | — |
| Exceptional items | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 5.01 | 0.00 | −2.01 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 120 | 120 | 161 | 175 | 227 | 293 | 234 | 154 | 201 | 170 | 179 | 180 |
| EPS (Rs) | 5.02 | 5.00 | 6.71 | 7.09 | 9.14 | 11.76 | 9.38 | 6.22 | 8.07 | 6.86 | 7.22 | 7.24 |
| Dividend payout % | 6.0% | 10.0% | 11.0% | 13.0% | 14.0% | 21.0% | 27.0% | 40.0% | 37.0% | 44.0% | 49.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.99 | 11.97 | 11.97 | 11.96 | 11.97 | 24.93 | 24.94 | 24.92 | 24.92 | 24.95 | 24.93 | 24.93 |
| Reserves | 363 | 469 | 596 | 751 | 1,095 | 1,250 | 1,551 | 1,736 | 1,833 | 1,981 | 2,076 | 2,185 |
| Borrowings | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 | 233 |
| Other Liabilities | 233 | 280 | 285 | 333 | 392 | 428 | 457 | 446 | 474 | 506 | 450 | 508 |
| Total Liabilities | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,177 | 2,382 | 2,496 | 2,717 | 2,763 | 2,951 |
| Fixed Assets | 473 | 533 | 543 | 527 | 850 | 984 | 941 | 990 | 1,153 | 1,377 | 1,348 | 1,370 |
| CWIP | 1.99 | 27.99 | 62.04 | 138 | 11.01 | 45.99 | 118 | 149 | 88.99 | 33.02 | 54.01 | 97.02 |
| Investments | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 | 339 | 195 | 226 | 108 | 344 | 437 |
| Other Assets | 366 | 436 | 464 | 585 | 749 | 811 | 779 | 1,048 | 1,027 | 1,198 | 1,017 | 1,047 |
| Inventories | 249 | 285 | 290 | 314 | 381 | 447 | 421 | 672 | 563 | 598 | 557 | 556 |
| Trade receivables | 82.02 | 109 | 123 | 173 | 223 | 172 | 181 | 251 | 270 | 358 | 312 | 299 |
| Cash & equivalents | 3.99 | 1.99 | 3.99 | 3.99 | 1.99 | 3.99 | 7.98 | 12.97 | 73.85 | 97.86 | 41.94 | 23.96 |
| Total Assets | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,177 | 2,382 | 2,496 | 2,717 | 2,763 | 2,951 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 107 | 159 | 179 | 153 | 123 | 318 | 511 | 55.80 | 399 | 234 | 405 | 347 |
| Cash from investing activity | −130 | −129 | −88.70 | −108 | −55.77 | −115 | −451 | 14.93 | −257 | −98.63 | −261 | −206 |
| Cash from financing activity | 21.09 | −31.11 | −89.32 | −46.20 | −68.29 | −204 | −56.17 | −70.23 | −138 | −106 | −163 | −147 |
| Net cash flow | −1.01 | −2.01 | 1.01 | 0.00 | −1.01 | 1.01 | 4.01 | 1.01 | 3.01 | 30.10 | −18.07 | −5.02 |
| Capex | 131 | 135 | 90.19 | 109 | 92.07 | 116 | 123 | 140 | 185 | 250 | 116 | 137 |
| Free cash flow | −23.05 | 25.05 | 90.16 | 46.10 | 32.06 | 203 | 391 | −82.13 | 216 | −11.01 | 291 | 213 |
| CFO / OP % | 72.0% | 89.0% | 103.0% | 78.0% | 64.0% | 97.0% | 121.0% | 33.0% | 133.9% | 74.0% | 120.0% | 111.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 22 | 25 | 29 | 34 | 36 | 27 | 29 | 35 | 36 | 46 | 42 | 41 |
| Inventory days | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 | 184 |
| Days payable | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 | 87 |
| Cash conversion cycle | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 | 138 |
| Working capital days | 15 | 13 | 20 | 28 | 43 | 58 | 45 | 76 | 60 | 69 | 63 | 90 |
| ROCE % | 30.0% | 30.0% | 26.0% | 30.0% | 26.0% | 24.0% | 26.0% | 18.0% | 12.0% | 14.0% | 11.0% | 11.0% |
For the Mar 2026 quarter, Relaxo Footwears reported sales of ₹752 Cr, up 8.0% year on year and net profit of ₹68.13 Cr, up 21.4% year on year. The operating margin was 17.0%.
Relaxo Footwears' sales for the year to Mar 2026 were ₹2,705 Cr; over the last twelve months they were ₹2,706 Cr.
Net profit for the year to Mar 2026 was ₹179 Cr, and ₹180 Cr over the last twelve months. Earnings per share over the same trailing period were ₹7.24.
Relaxo Footwears reported borrowings of ₹233 Cr at Mar 2026, against cash and equivalents of ₹23.96 Cr.
Cash from operations was ₹347 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹213 Cr.